253 related articles for article (PubMed ID: 28190002)
21. Evidence for a role of sterol 27-hydroxylase in glucocorticoid metabolism in vivo.
Vögeli I; Jung HH; Dick B; Erickson SK; Escher R; Funder JW; Frey FJ; Escher G
J Endocrinol; 2013 Nov; 219(2):119-29. PubMed ID: 24096962
[TBL] [Abstract][Full Text] [Related]
22. Retinal Hypercholesterolemia Triggers Cholesterol Accumulation and Esterification in Photoreceptor Cells.
Saadane A; Mast N; Dao T; Ahmad B; Pikuleva IA
J Biol Chem; 2016 Sep; 291(39):20427-39. PubMed ID: 27514747
[TBL] [Abstract][Full Text] [Related]
23. Brain Acetyl-CoA Production and Phosphorylation of Cytoskeletal Proteins Are Targets of CYP46A1 Activity Modulation and Altered Sterol Flux.
Mast N; Petrov AM; Prendergast E; Bederman I; Pikuleva IA
Neurotherapeutics; 2021 Jul; 18(3):2040-2060. PubMed ID: 34235635
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of a novel side chain modified Delta8(14)-15-ketosterol, a potential cholesterol lowering drug: 28-hydroxylation by CYP27A1.
Pettersson H; Norlin M; Andersson U; Pikuleva I; Björkhem I; Misharin AY; Wikvall K
Biochim Biophys Acta; 2008 Aug; 1781(8):383-90. PubMed ID: 18603016
[TBL] [Abstract][Full Text] [Related]
25. Drugs and Scaffold That Inhibit Cytochrome P450 27A1 In Vitro and In Vivo.
Lam M; Mast N; Pikuleva IA
Mol Pharmacol; 2018 Feb; 93(2):101-108. PubMed ID: 29192124
[TBL] [Abstract][Full Text] [Related]
26. A Rare Case of Cerebrotendinous Xanthomatosis Associated With a Mutation on COG8 Gene.
Ghoshouni H; Sarmadian R; Irilouzadian R; Biglari HN; Gilani A
J Investig Med High Impact Case Rep; 2023; 11():23247096231168109. PubMed ID: 37083278
[TBL] [Abstract][Full Text] [Related]
27. Late-onset Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.
Sasamura A; Akazawa S; Haraguchi A; Horie I; Ando T; Abiru N; Takei H; Nittono H; Une M; Kurosawa T; Murai T; Naruse H; Nakayama T; Kotani K; Remaley AT; Kawakami A
Intern Med; 2018 Jun; 57(11):1611-1616. PubMed ID: 29434128
[TBL] [Abstract][Full Text] [Related]
28. Could steroids mask the diagnosis of cerebrotendinous xanthomatosis?
Siman-Tov T; Meiner V; Gadoth N
J Neurol Sci; 2006 Apr; 243(1-2):83-6. PubMed ID: 16445943
[TBL] [Abstract][Full Text] [Related]
29.
Mast N; Anderson KW; Johnson KM; Phan TTN; Guengerich FP; Pikuleva IA
J Biol Chem; 2017 Aug; 292(31):12934-12946. PubMed ID: 28642370
[TBL] [Abstract][Full Text] [Related]
30. Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports.
Di Taranto MD; Gelzo M; Giacobbe C; Gentile M; Marotta G; Savastano S; Dello Russo A; Fortunato G; Corso G
Metab Brain Dis; 2016 Oct; 31(5):1185-8. PubMed ID: 27225395
[TBL] [Abstract][Full Text] [Related]
31. A novel frameshift mutation in the sterol 27-hydroxylase gene in an Egyptian family with cerebrotendinous xanthomatosis without cataract.
Abdel-Hamid MS; Issa MY; Otaify GA; Zaki MS
Metab Brain Dis; 2017 Apr; 32(2):311-315. PubMed ID: 28229379
[TBL] [Abstract][Full Text] [Related]
32. [Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects].
Lionnet C; Carra C; Ayrignac X; Levade T; Gayraud D; Castelnovo G; Besson G; Androdias G; Vukusic S; Confavreux C; Zaenker C; De Seze J; Collongues N; Blanc F; Tranchant C; Wallon D; Hannequin D; Gerdelat-Mas A; Brassat D; Clanet M; Zephir H; Outteryck O; Vermersch P; Labauge P
Rev Neurol (Paris); 2014; 170(6-7):445-53. PubMed ID: 24746394
[TBL] [Abstract][Full Text] [Related]
33. Three siblings with Cerebrotendinous Xanthomatosis: a novel mutation in the CYP27A1 gene.
Suh S; Kim HK; Park HD; Ki CS; Kim MY; Jin SM; Kim SW; Hur KY; Kim KW; Kim JH
Eur J Med Genet; 2012 Jan; 55(1):71-4. PubMed ID: 21958693
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
Mignarri A; Magni A; Del Puppo M; Gallus GN; Björkhem I; Federico A; Dotti MT
J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518
[TBL] [Abstract][Full Text] [Related]
35. Retinal Vascular Abnormalities and Microglia Activation in Mice with Deficiency in Cytochrome P450 46A1-Mediated Cholesterol Removal.
Saadane A; Mast N; Trichonas G; Chakraborty D; Hammer S; Busik JV; Grant MB; Pikuleva IA
Am J Pathol; 2019 Feb; 189(2):405-425. PubMed ID: 30448403
[TBL] [Abstract][Full Text] [Related]
36. Increased 27-hydroxycholesterol production during luteolysis may mediate the progressive decline in progesterone secretion.
Xu Y; Hutchison SM; Hernández-Ledezma JJ; Bogan RL
Mol Hum Reprod; 2018 Jan; 24(1):2-13. PubMed ID: 29177442
[TBL] [Abstract][Full Text] [Related]
37. Cholestanol metabolism in patients with cerebrotendinous xanthomatosis: absorption, turnover, and tissue deposition.
Bhattacharyya AK; Lin DS; Connor WE
J Lipid Res; 2007 Jan; 48(1):185-92. PubMed ID: 17012751
[TBL] [Abstract][Full Text] [Related]
38. Cholesterol redistribution triggered by CYP46A1 gene therapy improves major hallmarks of Niemann-Pick type C disease but is not sufficient to halt neurodegeneration.
Nunes MJ; Carvalho AN; Reis J; Costa D; Moutinho M; Mateus J; Mendes de Almeida R; Brito S; Risso D; Nunes S; Castro-Caldas M; Gama MJ; Rodrigues CMP; Xapelli S; Diógenes MJ; Cartier N; Chali F; Piguet F; Rodrigues E
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):166993. PubMed ID: 38142760
[TBL] [Abstract][Full Text] [Related]
39. Cholesterol 24-Hydroxylation by CYP46A1: Benefits of Modulation for Brain Diseases.
Petrov AM; Pikuleva IA
Neurotherapeutics; 2019 Jul; 16(3):635-648. PubMed ID: 31001737
[TBL] [Abstract][Full Text] [Related]
40. Cholesterol 24-hydroxylase: Brain cholesterol metabolism and beyond.
Moutinho M; Nunes MJ; Rodrigues E
Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):1911-1920. PubMed ID: 27663182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
